0000950123-21-014990.txt : 20211112
0000950123-21-014990.hdr.sgml : 20211112
20211112163832
ACCESSION NUMBER: 0000950123-21-014990
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210930
FILED AS OF DATE: 20211112
DATE AS OF CHANGE: 20211112
EFFECTIVENESS DATE: 20211112
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Column Group LLC
CENTRAL INDEX KEY: 0001833486
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20797
FILM NUMBER: 211404244
BUSINESS ADDRESS:
STREET 1: LETTERMAN DRIVE, BUILDING D, SUITE M-900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
BUSINESS PHONE: 415-865-2050
MAIL ADDRESS:
STREET 1: LETTERMAN DRIVE, BUILDING D, SUITE M-900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001833486
XXXXXXXX
09-30-2021
09-30-2021
false
Column Group LLC
Letterman Drive, Building D, Suite M-900
San Francisco
CA
94129
13F HOLDINGS REPORT
028-20797
Y
Certain shares holdings that are reported on this 13F were previously reported on a 13F filed by Peter Svennilson (CIK: 0001606074) (File No. 028-16412)
James Evangelista
Chief Financial Officer
(415) 865-2050
/s/ James Evangelista
San Francisco
CA
11-12-2021
0
7
879083
false
INFORMATION TABLE
2
7283.xml
INFORMATION TABLE FOR FORM 13F
Tenaya Therapeutics, Inc.
COM
87990A106
194116
9400290
SH
SOLE
9400290
0
0
Revolution Medicines Inc
COM
76155X100
92083
3347245
SH
SOLE
3347245
0
0
RAPT Therapeutics Inc
COM
75382E109
43532
1402008
SH
SOLE
1402008
0
0
ORIC Pharmaceuticals Inc.
COM
68622P109
99703
4768181
SH
SOLE
4768181
0
0
NGM Biopharmaceuticals Inc
COM
62921N105
323626
15396116
SH
SOLE
15396116
0
0
Surrozen, Inc.
COM
86889P109
65477
9248129
SH
SOLE
9248129
0
0
eFFECTOR Therapeutics Inc
COM
28202V108
60546
4309329
SH
SOLE
4309329
0
0